ChromoGenics AB logo

CHRO - ChromoGenics AB News Story

SEK9.65 -0.4  -3.5%

Last Trade - 07/05/21

Sector
Consumer Cyclicals
Size
Micro Cap
Market Cap £14.1m
Enterprise Value £11.0m
Revenue £1.26m
Position in Universe 1509th / 1838

BRIEF-ChromoGenics Q4 EBITDA Loss Narrows To SEK 7.6 Million

Fri 19th February, 2021 7:44am
Feb 19 (Reuters) - ChromoGenics AB  CHRO.ST :
    * Q4 NET SALES SEK 2.0 MILLION VERSUS SEK 8.1 MILLION YEAR
AGO
    * Q4 EBITDA LOSS SEK 7.6 MILLION VERSUS LOSS SEK 20.4
MILLION YEAR
AGO
    * PROPOSES NO DIVIDEND FOR THE 2020 FINANCIAL YEAR
    * ORDER VOLUME FOR Q1 2021 AMOUNTS TO SEK 8.8 (9.5) MILLION

Source text for Eikon:  ID: 
Further company coverage:  CHRO.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.